Kenneth A. Stauderman

CIK: 0001969388

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CALC

CalciMedica, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

CALC
CalciMedica, Inc.
Sep 24, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
180K shares-
CALC
CalciMedica, Inc.
Jul 28, 2025
Purchase(P)
Direct
1K shares at avg. $3.96$4K
CALC
CalciMedica, Inc.
Jul 25, 2025
Sale(S)
Indirect
1K shares at avg. $3.65$4K
CALC
CalciMedica, Inc.
Jul 1, 2025
Purchase(P)
Indirect
1K shares at avg. $1.85$2K
CALC
CalciMedica, Inc.
Jun 24, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
47.1K shares-
CALC
CalciMedica, Inc.
Apr 23, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
125K shares-
CALC
CalciMedica, Inc.
Apr 5, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
65.1K shares-

		Type	Shares	Price		Ownership
Sep 24, 2026	CALC CalciMedica, Inc.	Award(A) Employee Stock Option (Right to Buy)	180,000	-	-	Direct
Jul 28, 2025	CALC CalciMedica, Inc.	Purchase(P)	1,000	$3.96	$3,960	Direct
Jul 25, 2025	CALC CalciMedica, Inc.	Sale(S)	1,000	$3.65	$3,650	Indirect
Jul 1, 2025	CALC CalciMedica, Inc.	Purchase(P)	1,000	$1.85	$1,850	Indirect
Jun 24, 2025	CALC CalciMedica, Inc.	Award(A) Employee Stock Option (Right to Buy)	47,125	-	-	Direct
Apr 23, 2025	CALC CalciMedica, Inc.	Award(A) Employee Stock Option (Right to Buy)	125,000	-	-	Direct
Apr 5, 2025	CALC CalciMedica, Inc.	Award(A) Employee Stock Option (Right to Buy)	65,124	-	-	Direct

1-7 of 7 transactions

About Stauderman Kenneth A.

Stauderman Kenneth A. (SEC CIK 0001969388) files insider reports with the SEC as Chief Scientific Officer of CalciMedica, Inc. (CALC).

Signal8 holds 6 ownership filings by Stauderman Kenneth A., all Form 4s, filed between Apr 25, 2025 and Sep 28, 2026. Those filings report 7 transactions, from Apr 5, 2025 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Stauderman Kenneth A.'s filings is in LA JOLLA, CA.

Recent filings by Stauderman Kenneth A.

Sep 24, 2026: Grant or award of CALC derivative securities (Form 4, code A).
Jul 28, 2025: Open-market purchase of CALC shares (Form 4, code P).
Jul 25, 2025: Open-market sale of CALC shares (Form 4, code S).
Jul 1, 2025: Open-market purchase of CALC shares (Form 4, code P).
Jun 24, 2025: Grant or award of CALC derivative securities (Form 4, code A).

Other insiders filing for CalciMedica, Inc. (CALC)

Glicklich Alan, Director
Zaytsev Evgeny, Director
Guerard Frederic, Director
Shaw Allan, Director
WILSON ROBERT N, Director
Hebbar Sudarshan, Chief Medical Officer

How to read Form 4 transaction codes